Transactions of Japanese Society for Medical and Biological Engineering
Online ISSN : 1881-4379
Print ISSN : 1347-443X
ISSN-L : 1347-443X
Developing imaging biomarkers for early diagnosis of neurodegenerative diseases
Naruhiko Sahara
Author information
JOURNAL FREE ACCESS

2021 Volume Annual59 Issue Abstract Pages 164

Details
Abstract

Neurodegenerative diseases including Alzheimer's disease (AD) are common causes of death in developed countries. Neurofibrillary tangles composed of hyperphosphorylated tau proteins are one of pathological hallmarks of neurodegenerative diseases. Neurofibrillary lesions strongly corelated with cognitive deficits in neurodegenerative diseases. Recent advance of in vivo imaging techniques has opened a window to capture a real time event during brain aging. Our group recently established the positron emission tomography (PET) imaging of tau lesions using [18F]PM-PBB3 PET tracer to diagnose not only AD also non-AD tauopathies (e.g., Progressive supranuclear palsy, Corticobasal degeneration, and Chronic traumatic encephalopathy). In addition to clinical research, this tracer is a feasible to visualize tau pathologies in mouse models of tauopathy. Therefore, tau PET imaging is a translatable research tool between human and mouse tauopathies. Currently, investigating early detection of tauopathies during a transition from physiological tau proteins to pathological tau aggregates is one of our research achievements.

Content from these authors
© 2021 Japanese Society for Medical and Biological Engineering
Previous article Next article
feedback
Top